Decision/Risk Analysis · Denver, CO · Founded 2016 · Privately Held (backing)
Developer of a healthcare platform designed to create a new standard of care for coronary artery disease. Cleerly is based in Denver, CO and was founded in 2016. It has raised $410 million across 2 recorded rounds; the latest was a $51.3 million later-stage round in Nov 2024.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$410.3M
Last round
Later Stage VC
Nov 2024
No prints on record
No secondary trades in Cleerly shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Cleerly stock.
